Article
Insurers are beginning to think so, and more of them are paying for it. Are you prepared?
FDA approves Zepbound as first ever prescription drug to treat sleep apnea with obesity
Ep 45: Vaccine hesitancy with Jay W. Lee, MD, MPH, FAAFP
U.S. life expectancy jumped last year; FDA approves first mesenchymal stromal cell therapy to treat SR-aGVHD in pediatric patients; popular vitamins won’t prevent falls or fractures in older adults – Morning Medical Update
Ep 44: Noncompete clauses with Emma Schuering, JD
Great expectations may need adjusting
Mastering the shift to value-based care: 3 strategies for organization-wide success
